Cargando…

Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia

BACKGROUND: Coronary artery aneurysm (CAA) and coronary artery ectasia (CAE) may be two different types of coronary artery dilatation with unknown etiology. This study aimed to compare the differences between CAA and CAE and to investigate their pathogenesis and the necessity of antiplatelet therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wei, Wang, Xingxu, Huang, Zhenghao, Li, Xiaolin, Luo, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656333/
https://www.ncbi.nlm.nih.gov/pubmed/33209413
http://dx.doi.org/10.21037/jtd-20-1579
_version_ 1783608359401816064
author Wei, Wei
Wang, Xingxu
Huang, Zhenghao
Li, Xiaolin
Luo, Yu
author_facet Wei, Wei
Wang, Xingxu
Huang, Zhenghao
Li, Xiaolin
Luo, Yu
author_sort Wei, Wei
collection PubMed
description BACKGROUND: Coronary artery aneurysm (CAA) and coronary artery ectasia (CAE) may be two different types of coronary artery dilatation with unknown etiology. This study aimed to compare the differences between CAA and CAE and to investigate their pathogenesis and the necessity of antiplatelet therapy. METHODS: One hundred patients each with confirmed CAA, CAE, and normal coronary artery (NCA) from September 2017 to July 2019 were included. All patients completed examinations of the ankle-brachial index (ABI), pulse wave rate, and carotid ultrasonography; and were tested for routine blood, lipid, and immune parameters. Blood samples were collected 1 week after the withdrawal of antiplatelet drugs, and vascular inflammatory indexes, platelet activation indexes, thromboelastography, and the platelet aggregation rate were measured. Analysis of variance and the chi-square or Fisher exact test were used for statistical analysis. RESULTS: The perinuclear anti-neutrophil cytoplasmic antibody (ANCA), endothelial-1, matrix metalloproteinase-9, and tumor necrosis factor-α were significantly higher in CAE than in NCA, while cytoplasmic ANCA was appreciably higher in CAE than in CAA (P<0.05). Myeloperoxidase and growth/differentiation factor-15 were significantly higher in CAE than in CAA and NCA (P<0.05). ABI was significantly lower in CAA and CAE than in NCA (P<0.05), low-density lipoprotein/high-density lipoprotein was significantly higher in CAA than in NCA (P<0.05), and the detection rate of carotid artery thickening was significantly higher in CAA than in CAE and NCA (P<0.05). The Gensini and SYNTAX scores were significantly higher in CAA than in CAE (P<0.05). The percentages of CD62P and PAC-1 were higher in CAA and CAE than in NCA (P<0.05). The arachidonic acid aggregation rate in CAA and adenosine 5'-diphosphate aggregation rate in CAE were significantly higher than in NCA (P<0.05). The values of thrombin formation time and reaction time were significantly lower in CAE than in NCA (P<0.05), and the α angle was significantly higher in CAE than in NCA. CONCLUSIONS: CAE was closely related to inflammation, whereas CAA was closely related to atherosclerosis. Platelet activation was present in both diseases; therefore, antiplatelet therapy is recommended.
format Online
Article
Text
id pubmed-7656333
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-76563332020-11-17 Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia Wei, Wei Wang, Xingxu Huang, Zhenghao Li, Xiaolin Luo, Yu J Thorac Dis Original Article BACKGROUND: Coronary artery aneurysm (CAA) and coronary artery ectasia (CAE) may be two different types of coronary artery dilatation with unknown etiology. This study aimed to compare the differences between CAA and CAE and to investigate their pathogenesis and the necessity of antiplatelet therapy. METHODS: One hundred patients each with confirmed CAA, CAE, and normal coronary artery (NCA) from September 2017 to July 2019 were included. All patients completed examinations of the ankle-brachial index (ABI), pulse wave rate, and carotid ultrasonography; and were tested for routine blood, lipid, and immune parameters. Blood samples were collected 1 week after the withdrawal of antiplatelet drugs, and vascular inflammatory indexes, platelet activation indexes, thromboelastography, and the platelet aggregation rate were measured. Analysis of variance and the chi-square or Fisher exact test were used for statistical analysis. RESULTS: The perinuclear anti-neutrophil cytoplasmic antibody (ANCA), endothelial-1, matrix metalloproteinase-9, and tumor necrosis factor-α were significantly higher in CAE than in NCA, while cytoplasmic ANCA was appreciably higher in CAE than in CAA (P<0.05). Myeloperoxidase and growth/differentiation factor-15 were significantly higher in CAE than in CAA and NCA (P<0.05). ABI was significantly lower in CAA and CAE than in NCA (P<0.05), low-density lipoprotein/high-density lipoprotein was significantly higher in CAA than in NCA (P<0.05), and the detection rate of carotid artery thickening was significantly higher in CAA than in CAE and NCA (P<0.05). The Gensini and SYNTAX scores were significantly higher in CAA than in CAE (P<0.05). The percentages of CD62P and PAC-1 were higher in CAA and CAE than in NCA (P<0.05). The arachidonic acid aggregation rate in CAA and adenosine 5'-diphosphate aggregation rate in CAE were significantly higher than in NCA (P<0.05). The values of thrombin formation time and reaction time were significantly lower in CAE than in NCA (P<0.05), and the α angle was significantly higher in CAE than in NCA. CONCLUSIONS: CAE was closely related to inflammation, whereas CAA was closely related to atherosclerosis. Platelet activation was present in both diseases; therefore, antiplatelet therapy is recommended. AME Publishing Company 2020-10 /pmc/articles/PMC7656333/ /pubmed/33209413 http://dx.doi.org/10.21037/jtd-20-1579 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Wei, Wei
Wang, Xingxu
Huang, Zhenghao
Li, Xiaolin
Luo, Yu
Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia
title Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia
title_full Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia
title_fullStr Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia
title_full_unstemmed Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia
title_short Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia
title_sort difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary artery ectasia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656333/
https://www.ncbi.nlm.nih.gov/pubmed/33209413
http://dx.doi.org/10.21037/jtd-20-1579
work_keys_str_mv AT weiwei differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia
AT wangxingxu differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia
AT huangzhenghao differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia
AT lixiaolin differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia
AT luoyu differenceininflammationatherosclerosisandplateletactivationbetweencoronaryarteryaneurysmandcoronaryarteryectasia